Skinive

Skinive is an AI skin scanner that analyzes a smartphone photo of a mole, rash or other visible skin concern and returns a risk assessment covering more than 55 conditions, including signs of skin cancer, HPV, fungal infections, acne, eczema and psoriasis. It is CE marked medical software developed with dermatologists, and it flags findings that warrant a professional examination rather than offering a diagnosis. Three audiences use it. Individuals use the consumer app on iOS and Android for self checks, regular monitoring with change tracking over time, and 3D full body mole mapping to document lesions. Clinicians and dermatologists use Skinive MD, a version built for clinical workflow support and lesion documentation. Developers integrate the same analysis through an API into digital health and telemedicine applications. Real time camera guidance helps users capture a usable image before analysis runs. Pricing for the consumer app is not published on the website; the app is distributed through the Apple App Store and Google Play. Pricing for Skinive MD and API access is not published and is arranged with the company. Skinive B.V. is based in Amsterdam and has received EU Horizon 2020 funding. As with any consumer dermatology tool, a risk score is a prompt to seek care, not a substitute for a clinical examination.